首页> 美国卫生研究院文献>Aging (Albany NY) >Rapamycin for longevity: opinion article
【2h】

Rapamycin for longevity: opinion article

机译:雷帕霉素延年益寿:评论文章

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

From the dawn of civilization, humanity has dreamed of immortality. So why didn’t the discovery of the anti-aging properties of mTOR inhibitors change the world forever? I will discuss several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today. Furthermore, the alternative to the reversible (and avoidable) side effects of rapamycin/everolimus are the irreversible (and inevitable) effects of aging: cancer, stroke, infarction, blindness and premature death. I will also discuss why it is more dangerous not to use anti-aging drugs than to use them and how rapamycin-based drug combinations have already been implemented for potential life extension in humans. If you read this article from the very beginning to its end, you may realize that the time is now.
机译:从文明的曙光开始,人类就梦想着永生。那么,为什么发现mTOR抑制剂的抗衰老特性不会永远改变世界呢?我将讨论几个原因,包括担心雷帕霉素,依维莫司和其他临床批准药物的实际和虚构的副作用,认为目前尚无真正的副作用排除其作为抗衰老药物的使用。此外,雷帕霉素/依维莫司的可逆(和可避免)副作用的替代方法是衰老的不可逆(和不可避免)效果:癌症,中风,梗塞,失明和过早死亡。我还将讨论为什么不使用抗衰老药物比使用抗衰老药物更危险,以及基于雷帕霉素的药物组合已被实施以延长人类的潜在寿命。如果您从头到尾阅读本文,您可能会意识到现在已经到了。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号